Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 18.2869.62-19.54-53.8883.25

What is the latest EBIT Growth ratio of AUROBINDO PHARMA ?

The latest EBIT Growth ratio of AUROBINDO PHARMA is 18.28 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202518.28
Mar202469.62
Mar2023-19.54
Mar2022-53.88
Mar202183.25

How is EBIT Growth of AUROBINDO PHARMA Trending?

Years EBIT Growth % Change
Mar2025 18.28
-73.74
Mar2024 69.62
Positive
Mar2023 -19.54
Negative
Mar2022 -53.88
Negative
Mar2021 83.25 -

Other Financial Ratios of AUROBINDO PHARMA


Compare EBIT Growth ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹84,713.3 Cr 1.4% -1.7% 26.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,620.0 Cr 1% -0.9% 6.8% Stock Analytics
DIVIS LABORATORIES ₹176,087.0 Cr 1.8% -2.3% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹154,837.0 Cr 3.7% 6.5% 44.9% Stock Analytics
CIPLA ₹112,194.0 Cr 0% 4.7% -8% Stock Analytics
DR REDDYS LABORATORIES ₹106,328.0 Cr -0.2% 0.7% -3.4% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

1.4%

-1.7%

26.1%

SENSEX

1.7%

1.3%

-7.3%


You may also like the below Video Courses